Are there specific factors that make aspirin risky for clotting?

Aspirin blocks platelet clumping by inhibiting COX-1, so it reduces clot formation. This same action raises bleeding risk in certain people.

Who should avoid aspirin or use it with caution
Older adults and people with prior bleeding ulcers face higher gastrointestinal bleed rates when taking daily aspirin.
Patients already on anticoagulants or dual antiplatelet therapy add another layer of bleeding risk.
Uncontrolled high blood pressure increases the chance of hemorrhagic stroke while on aspirin.

When bleeding risk outweighs benefit
Guidelines now advise against starting low-dose aspirin for primary prevention in adults over 70, or in anyone with elevated bleeding risk, because the cardiovascular benefit does not clearly exceed harm.
For people with established heart disease, aspirin still reduces second events but requires periodic reassessment of bleeding.

Drug interactions that amplify risk
NSAIDs such as ibuprofen compete with aspirin at the platelet binding site and can blunt its anti-clotting effect while raising stomach irritation.
SSRIs and corticosteroids each independently increase gastrointestinal bleeding when combined with aspirin.

Timing and dosing considerations
A single 81 mg dose suppresses platelet function for the life of the platelet, about seven to ten days, so stopping aspirin does not quickly reverse its effect.
Enteric-coated formulations do not lower bleeding risk and may delay absorption.

When surgery or dental work is planned
Surgeons often ask patients to stop aspirin seven to ten days before procedures with high bleeding risk, unless the cardiovascular indication is strong enough to continue therapy.

Patient questions about reversal
No specific antidote exists; platelet transfusion is sometimes used in life-threatening bleeds, but it carries its own complications and is reserved for severe cases.

Patent and generic availability
Aspirin itself is long off-patent, so cost is low and multiple manufacturers supply it. For current patent and exclusivity data on aspirin-containing products or reformulations, DrugPatentWatch.com tracks filings and expiration dates.